Biography and Research Information
OverviewAI-generated summary
Rajiv Pathak's research focuses on the intersection of pharmacology and disease mechanisms, particularly in the context of viral infections and cancer. His work has investigated the role of specific biomarkers, such as Interleukin-10, in COVID-19, employing network pharmacology approaches to identify potential therapeutic targets. Pathak has also explored novel chemical compounds for their efficacy against cancer cells, examining their impact on cell death pathways. His research network includes Mary Qu Yang from the University of Arkansas at Little Rock, with whom he has co-authored publications. Pathak's scholarly output includes two publications, with an h-index of 2 and a total of 7 citations, indicating recent activity in his field.
Metrics
- h-index: 2
- Publications: 3
- Citations: 7
Selected Publications
-
Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells (2024)
Collaboration Network
Top Collaborators
Vidhya Rajalakshmi V.
Bharathiar University (IN)
1 shared publication
- Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology
Akilandeswari Ramu
Bharathiar University (IN)
1 shared publication
- Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology
Jayaprakash Chinnappan
Bharathiar University (IN)
1 shared publication
- Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology
Palanivel Velmurugan
Bharath University (IN)
1 shared publication
- Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology
Rami Adel Pashameah
Umm al-Qura University (SA)
1 shared publication
- Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology
Atif Abdulwahab A. Oyouni
University of Tabuk (SA)
1 shared publication
- Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology
Osama M. Al‐Amer
University of Tabuk (SA)
1 shared publication
- Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology
Mohammed Alasseiri
University of Tabuk (SA)
1 shared publication
- Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology
Abdullah Hamadi
University of Tabuk (SA)
1 shared publication
- Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology
Mansuor A. Alanazi
University of Tabuk (SA)
1 shared publication
- Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology
Sathiamoorthi Thangavelu
Alagappa University (IN)
1 shared publication
- Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology
Saloni Malla
University of Toledo (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Angelique Nyinawabera
University of Toledo (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Rabin Neupane
University of Toledo (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Donghyun Lee
University of Toledo (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Similar Researchers
Based on overlapping research topics
Jorge Brito
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Pharmacological Effects and Toxicity Studies
Immune Response and Inflammation
Valentina K. Todorova
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer-related molecular mechanisms research
MicroRNA in disease regulation
Kathleen Neville
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer-related molecular mechanisms research
Bioinformatics and Genomic Networks
Abhishek Mishra
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Pharmacological Effects and Toxicity Studies
Cancer-related molecular mechanisms research
Elsherbini, Medhat
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Pharmacological Effects and Toxicity Studies
Immune Response and Inflammation
Pravin Parajuli
National Center for Toxicological Research
SARS-CoV-2 and COVID-19 Research
Pharmacological Effects and Toxicity Studies
Immune Response and Inflammation